Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2025-12-24 @ 9:26 PM
NCT ID:
NCT00130832
Eligibility Criteria:
Inclusion Criteria:
* Infants in good health
Exclusion Criteria:
* Previous administration of any oral poliovirus vaccine (OPV) and rotavirus vaccine
* Receipt of inactivated poliovirus vaccine (IPV) prior to the first dose of either study vaccine, or at any time during the course of the study
* Any condition resulting in depressed immunity
* Any allergy to any vaccine component as stated in the package circulars
* Allergies to polymyxin B, neomycin or any other antibiotics
* Receipt of intramuscular, oral, or intravenous corticosteroid treatment
* History of congenital abdominal disorders, intussusception, or abdominal surgery; clinical evidence of active gastrointestinal illness
* History of known prior rotavirus gastroenteritis, chronic diarrhea, or failure to thrive
* Prior receipt of a blood transfusion or blood products, including immunoglobulin
* Fever, with a rectal temperature of ≥38.1°C (≥ 100.5°F) at the time of immunization
* Infants residing in a household with an immunocompromised person
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Weeks
Maximum Age:
12 Weeks
Study:
NCT00130832
Study Brief:
Protocol Section:
NCT00130832